Background: Primary biliary cirrhosis (PBC) is characterised by intra-hepat
ic immune-mediated cholangiopathy (non-suppurative destructive cholangitis
(NSDC)). Although auto-reactive immune responses against pyruvate dehydroge
nase complex (PDC) have been characterised in PBC, the lack of an animal mo
del of the disease has limited study of the mechanisms of disease induction
and the development of novel approaches to therapy. Aims: To develop and v
alidate a mouse model of immune-mediated cholangiopathy relevant for future
use in the study of the aetio-pathogenesis and therapy of PBC. Methods: Fe
male SJL/J, C57BL/6, NOD and BALB/c mice were sensitised with PDC, its puri
fied E2/E3BP component, and a PDC-E2 derived peptide p163 (a dominant T-cel
l epitope in humans) in complete Freund's adjuvant (CFA). Morphological cha
nges were assessed under light microscopy by a hepatic histopathologist bli
nded to the experimental details. Antibody responses to PDC were studied by
ELISA and PDC inhibition assay. Results: An initial series of experiments
was performed to survey the susceptibility of female mice of a range of str
ains to the induction of NSDC by i.p. sensitisation with PDC, PDC-E2/E3BP o
r p163 in CFA. Although each animal showed a specific antibody response fol
lowing sensitisation, it was found that NSDC development (assessed at 30 we
eks post-sensitisation) was restricted to SJL/J mice following sensitisatio
n with any of the mitochondrial antigen preparations. A subsequent series o
f experiments was performed to examine the specificity and aetiology of thi
s disease. Significant bile duct lesions were only seen in SJL/J animals fo
llowing sensitisation with CFA containing PDC, and were absent from CFA onl
y and un-sensitised controls. Kinetic analysis revealed that this pathology
developed slowly, but a high incidence of animals with severe lesions was
observed after 30 weeks. Conclusions: We have described a model of experime
ntal autoimmune cholangitis (EAC) with immunological (anti-PDC antibodies)
and histological (immune-mediated cholangiopathy) features suggestive of PB
C. This model may be useful in further defining the role of self-tolerance
breakdown in the development of this condition.